Market Access News | pharmaphorum

News

Eyes on GSK as Pfizer prepares to sell consumer division

GlaxoSmithKline saw its share price fall 6% yesterday after releasing underwhelming figures in Q3, and leaving investors uncertain about its future dividend payments.

News

Biogen sees Spinraza slow down in Q3, bullish on Alzheimer's...

Biogen has given investors a pleasant surprise with better-than-expected profits in Q3, but has puzzled analysts with a rapid slowdown for its new rare disease drug Spinraza.

News

UK business leaders: Brexit transition deal needed urgently

Leaders of big and small businesses across the UK say the government must secure a Brexit transition deal soon, or face companies freezing investment and relocating some staff to Europe.

News